Comment diagnostiquer une maladie du tube digestif inférieur ?

Des examens comme la coloscopie et les analyses de selles sont utilisés.

Quels tests sont utilisés pour détecter le cancer colorectal ?

La coloscopie et les tests de sang occulte dans les selles sont courants.

Quels symptômes nécessitent une consultation médicale ?

Des douleurs abdominales persistantes, des saignements ou des changements de selles.

Comment évaluer une inflammation intestinale ?

Des examens d'imagerie et des biopsies peuvent être nécessaires.

Quel rôle joue l'endoscopie dans le diagnostic ?

L'endoscopie permet d'examiner directement l'intérieur du tube digestif.

Quels sont les symptômes d'une colite ?

Les symptômes incluent des douleurs abdominales, des diarrhées et des saignements.

Comment reconnaître le syndrome de l'intestin irritable ?

Il se manifeste par des douleurs abdominales et des changements de transit intestinal.

Quels signes indiquent une obstruction intestinale ?

Des douleurs abdominales sévères, des vomissements et une absence de selles.

Quels symptômes sont associés à la maladie de Crohn ?

Les symptômes incluent des douleurs abdominales, des diarrhées et une perte de poids.

Quels symptômes peuvent signaler une diverticulite ?

Des douleurs dans le bas-ventre, de la fièvre et des changements dans les selles.

Comment prévenir le cancer colorectal ?

Un dépistage régulier, une alimentation riche en fibres et l'exercice sont essentiels.

Quels aliments favorisent la santé du tube digestif inférieur ?

Les aliments riches en fibres, comme les fruits, légumes et grains entiers, sont bénéfiques.

Comment réduire le risque de diverticulite ?

Une alimentation riche en fibres et une bonne hydratation peuvent aider à prévenir la diverticulite.

Quel rôle joue l'exercice dans la santé intestinale ?

L'exercice régulier aide à maintenir un transit intestinal sain et à prévenir les maladies.

Comment éviter les infections intestinales ?

Pratiquer une bonne hygiène alimentaire et se laver les mains régulièrement est crucial.

Quels traitements sont disponibles pour la colite ?

Les traitements incluent des anti-inflammatoires et des modifications alimentaires.

Comment traiter le syndrome de l'intestin irritable ?

Le traitement peut inclure des médicaments, des changements alimentaires et de la thérapie.

Quelles sont les options pour traiter une obstruction intestinale ?

Le traitement peut nécessiter une intervention chirurgicale ou des soins médicaux.

Quels médicaments sont utilisés pour la maladie de Crohn ?

Des immunosuppresseurs et des anti-inflammatoires sont souvent prescrits.

Comment se traite la diverticulite ?

Le traitement peut inclure des antibiotiques et, dans certains cas, une chirurgie.

Quelles sont les complications de la maladie de Crohn ?

Les complications incluent des fistules, des obstructions et un risque accru de cancer.

Quels risques sont associés à une colite ulcéreuse ?

Les risques incluent des saignements, des perforations et un cancer colorectal.

Quelles complications peuvent survenir avec une diverticulite ?

Les complications incluent des abcès, des perforations et des infections.

Quels sont les effets secondaires des traitements du tube digestif inférieur ?

Les effets secondaires peuvent inclure des nausées, des diarrhées et des infections.

Comment une obstruction intestinale peut-elle être fatale ?

Une obstruction non traitée peut entraîner une perforation intestinale et une septicémie.

Quels sont les facteurs de risque du cancer colorectal ?

L'âge, les antécédents familiaux et un mode de vie sédentaire augmentent le risque.

Comment l'alimentation influence-t-elle les maladies intestinales ?

Une alimentation riche en graisses et pauvre en fibres peut augmenter le risque de maladies intestinales.

Quels sont les facteurs de risque de la maladie de Crohn ?

Les antécédents familiaux, le tabagisme et certaines infections augmentent le risque.

Quel rôle joue le stress dans les troubles intestinaux ?

Le stress peut aggraver les symptômes des troubles intestinaux comme le syndrome de l'intestin irritable.

Comment l'âge affecte-t-il la santé intestinale ?

Le vieillissement peut augmenter le risque de maladies intestinales et de complications.

Tube digestif inférieur - Informations médicales vérifiées

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia.

15 Dec 2022

DOI: 10.4102/phcfm.v14i1.3736 PMID: 36546488

Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Pro... To determine the correlation between the PSA, IPSS and PV in men of African descent.... This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital.... The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from t... The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS w... This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into th...

Male Humans Middle Aged Prostatic Hyperplasia Prostate-Specific Antigen +2 autres

Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.

17 10 2023

DOI: 10.23750/abm.v94i5.13751 PMID: 37850783

We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...

Male Humans Middle Aged Prostatitis Prostate +5 autres

Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis.

12 2022

DOI: 10.1016/j.jvir.2022.08.006 PMID: 35964881

To compare the cost effectiveness of prostatic artery embolization (PAE) with that of transurethral resection of the prostate (TURP) for the treatment of medically refractory benign prostatic hyperpla... A cost-effectiveness analysis with Markov modeling was performed, comparing the clinical course after PAE with that after TURP for 3 years. Probabilities were obtained from the available literature, a... Base case calculation showed comparable outcomes (PAE, 2.845 QALY; TURP, 2.854 QALY), with a cost difference of $3,104 (PAE, $2,934; TURP, $6,038). The incremental cost-effectiveness ratio was $360,24... PAE is a cost-effective strategy to treat medically refractory BPH, resulting in comparable health benefits at a lower cost than that of TURP even when accounting for extreme alterations in adverse ev...

Aged United States Male Humans Prostatic Hyperplasia +7 autres

Prostate organogenesis.

15 06 2022

DOI: 10.1242/dev.200394 PMID: 35726824

Prostate organogenesis begins during embryonic development and continues through puberty when the prostate becomes an important exocrine gland of the male reproductive system. The specification and gr...

Androgens Epithelial Cells Epithelium Humans Male +3 autres

Prostatic Urethral Length as a Predictor for Surgery in Benign Prostatic Hyperplasia.

10 Mar 2023

DOI: 10.33314/jnhrc.v20i3.4613 PMID: 36974872

Benign prostatic hyperplasia is associated with structural and morphological changes including elongation of prostatic urethral length. The aim of our study was to assess whether prostatic urethral le... This prospective observational study was conducted over a 12-months duration. All the patients who presented with lower urinary tract symptoms secondary to benign prostatic hyperplasia were evaluated ... A total of 153 patients were included in the study. Eighty-three (54.2%) patients underwent surgery during the study period. Prostate volume, intravesical prostatic protrusion, post-void residual volu... BPH patients with longer PUL may require surgical management. PUL measured by TRUS may be a predicting factor for the need of surgery in BPH Keywords: Benign prostatic hyperplasia; lower urinary tract...

Male Humans Prostate Prostatic Hyperplasia Prostate-Specific Antigen +2 autres

Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer.

27 Dec 2022

DOI: 10.1186/s12957-022-02841-6 PMID: 36572885

Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin... A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch... Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ... Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...

Male Humans Middle Aged Aged Prostatic Neoplasms +7 autres

The influence of prostate volume on clinical parameters in prostate cancer screening.

Oct 2022

DOI: 10.1002/jcla.24700 PMID: 36098911

The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV).... The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr... In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/... Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...

Biomarkers Early Detection of Cancer Humans Male Prostate +4 autres

Relationships between holmium laser enucleation of the prostate and prostate cancer.

04 2023

DOI: 10.1038/s41585-022-00678-y PMID: 36418491

Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...

Male Humans Prostate Prostatic Hyperplasia Prostate-Specific Antigen +7 autres

Prostate health index (PHI) as an accurate prostate cancer predictor.

Sep 2023

DOI: 10.1007/s00432-023-04860-6 PMID: 37204514

This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population.... A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an... 140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand... The PHI test improves PCa detection compared to tPSA in our population....

Male Humans Prostate-Specific Antigen Prostate Prostatic Neoplasms +3 autres

Prostate Health Index Density Outperforms Prostate-specific Antigen Density in the Diagnosis of Clinically Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging of the Prostate: A Multicenter Evaluation.

Jul 2023

DOI: 10.1097/JU.0000000000003450 PMID: 37036248

We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy.... This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf... A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta... Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...

Male Humans Prostatic Neoplasms Prostate Prostate-Specific Antigen +3 autres

Tube digestif inférieur : Questions médicales fréquentes

Termes MeSH sélectionnés :

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Sous-catégories

Iléum

Gros intestin

Jéjunum

Valvule iléocaecale

Canal anal

Caecum

Côlon

Rectum

Appendice vermiforme

Côlon ascendant

Côlon descendant

Côlon sigmoïde

Côlon transverse

Auteurs principaux

Sources (10000 au total)